Exhibit 99.1
KULICKE AND SOFFA INDUSTRIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET
(in thousands)
| | | | | | | | | | | | | | | | |
| | December 31, 2005 | |
| | Company Historical (1) | | | Sale of Wafer Test Business (2) | | | Pro Forma Adjustments | | | Company Pro Forma Combined | |
ASSETS | | | | | | | | | | | | | | | | |
Current assets: | | | | | | | | | | | | | | | | |
Cash and cash equivalents | | $ | 84,320 | | | $ | — | | | $ | 9,000 | (4)(a) | | $ | 93,320 | |
Restricted cash | | | 10,255 | | | | — | | | | — | | | | 10,255 | |
Short-term investments | | | 7,222 | | | | — | | | | — | | | | 7,222 | |
Accounts and notes receivable, net | | | 179,520 | | | | (11,192 | ) | | | 5,192 | (4)(b) | | | 173,520 | |
Inventories, net | | | 62,926 | | | | (6,002 | ) | | | — | | | | 56,924 | |
Prepaid expenses and other current assets | | | 14,117 | | | | — | | | | — | | | | 14,117 | |
Deferred income taxes | | | 1,567 | | | | — | | | | — | | | | 1,567 | |
| | | | | | | | | | | | | | | | |
Total current assets | | | 359,927 | | | | (17,194 | ) | | | 14,192 | | | | 356,925 | |
| | | | |
Property, plant and equipment, net | | | 44,372 | | | | (10,512 | ) | | | — | | | | 33,860 | |
Goodwill | | | 29,684 | | | | — | | | | — | | | | 29,684 | |
Other assets | | | 5,835 | | | | — | | | | — | | | | 5,835 | |
| | | | | | | | | | | | | | | | |
TOTAL ASSETS | | $ | 439,818 | | | $ | (27,706 | ) | | $ | 14,192 | | | $ | 426,304 | |
| | | | | | | | | | | | | | | | |
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) | | | | | | | | | | | | | | | | |
Current liabilities: | | | | | | | | | | | | | | | | |
Current portion of long-term debt | | $ | 9,970 | | | $ | — | | | $ | — | | | $ | 9,970 | |
Accounts payable | | | 80,523 | | | | (2,445 | ) | | | — | | | | 78,078 | |
Accrued expenses | | | 32,017 | | | | — | | | | — | | | | 32,017 | |
Income taxes payable | | | 20,615 | | | | — | | | | — | | | | 20,615 | |
| | | | | | | | | | | | | | | | |
Total current liabilities | | | 143,125 | | | | (2,445 | ) | | | — | | | | 140,680 | |
| | | | |
Long-term debt | | | 270,000 | | | | — | | | | — | | | | 270,000 | |
Other liabilities | | | 6,610 | | | | — | | | | — | | | | 6,610 | |
Deferred income taxes | | | 23,207 | | | | — | | | | — | | | | 23,207 | |
| | | | | | | | | | | | | | | | |
Total liabilities | | | 442,942 | | | | (2,445 | ) | | | — | | | | 440,497 | |
| | | | | | | | | | | | | | | | |
Commitments and contingencies | | | — | | | | — | | | | — | | | | — | |
| | | | |
Shareholders’ equity (deficit): | | | | | | | | | | | | | | | | |
Common stock, no par value | | | 221,305 | | | | — | | | | — | | | | 221,305 | |
Accumulated deficit | | | (218,692 | ) | | | — | | | | (11,069 | )(4)(c) | | | (229,761 | ) |
Accumulated other comprehensive loss | | | (5,737 | ) | | | — | | | | — | | | | (5,737 | ) |
| | | | | | | | | | | | | | | | |
Total shareholders’ equity (deficit) | | | (3,124 | ) | | | — | | | | (11,069 | ) | | | (14,193 | ) |
| | | | | | | | | | | | | | | | |
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT) | | $ | 439,818 | | | $ | (2,445 | ) | | $ | (11,069 | ) | | $ | 426,304 | |
| | | | | | | | | | | | | | | | |
KULICKE AND SOFFA INDUSTRIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | For the Three Months Ended December 31, 2005 | |
| | Company Historical (1) | | | Sale of Wafer Test Business (2) | | | Pro Forma Adjustments | | | Company Pro Forma Combined | |
Net revenue | | $ | 228,100 | | | $ | (14,790 | ) | | $ | — | | | $ | 213,310 | |
| | | | |
Cost of sales | | | 157,223 | | | | (11,912 | ) | | | — | | | | 145,311 | |
| | | | | | | | | | | | | | | | |
Gross profit | | | 70,877 | | | | (2,878 | ) | | | — | | | | 67,999 | |
| | | | | | | | | | | | | | | | |
Selling, general and administrative | | | 27,933 | | | | (5,408 | ) | | | 1,184 | (4)(d) | | | 23,709 | |
Research and development, net | | | 12,179 | | | | (2,266 | ) | | | — | | | | 9,913 | |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 40,112 | | | | (7,674 | ) | | | 1,184 | | | | 33,622 | |
| | | | | | | | | | | | | | | | |
Income from operations | | | 30,765 | | | | 4,796 | | | | (1,184 | ) | | | 34,377 | |
| | | | |
Interest income | | | 712 | | | | — | | | | — | | | | 712 | |
Interest expense | | | (958 | ) | | | — | | | | — | | | | (958 | ) |
| | | | | | | | | | | | | | | | |
Income from operations before income taxes | | | 30,519 | | | | 4,796 | | | | (1,184 | ) | | | 34,131 | |
| | | | |
Provision for income taxes | | | 5,218 | | | | 32 | | | | — | | | | 5,250 | |
| | | | | | | | | | | | | | | | |
Net income | | $ | 25,301 | | | $ | 4,764 | | | $ | (1,184 | ) | | $ | 28,881 | |
| | | | | | | | | | | | | | | | |
Net income per share: | | | | | | | | | | | | | | | | |
Basic | | $ | 0.49 | | | | | | | | | | | $ | 0.55 | |
| | | | | | | | | | | | | | | | |
Diluted | | $ | 0.38 | | | | | | | | | | | $ | 0.43 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 52,044 | | | | | | | | | | | | 52,044 | |
Diluted | | | 68,239 | | | | | | | | | | | | 68,239 | |
KULICKE AND SOFFA INDUSTRIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | For the Three Months Ended December 31, 2004 | |
| | Company Historical (1) | | | Sale of Wafer Test Business (2) | | | Pro Forma Adjustments | | | Company Pro Forma Combined | |
Net revenue | | $ | 116,321 | | | $ | (14,017 | ) | | $ | — | | | $ | 102,304 | |
| | | | |
Cost of sales | | | 89,943 | | | | (14,574 | ) | | | — | | | | 75,369 | |
| | | | | | | | | | | | | | | | |
Gross profit | | | 26,378 | | | | 557 | | | | — | | | | 26,935 | |
| | | | | | | | | | | | | | | | |
Selling, general and administrative | | | 22,073 | | | | (5,246 | ) | | | 1,344 | (4)(d) | | | 18,171 | |
Research and development, net | | | 8,878 | | | | (1,171 | ) | | | — | | | | 7,707 | |
Gain on sale of assets | | | (1,875 | ) | | | 1,497 | | | | — | | | | (378 | ) |
Amortization of intangible assets | | | 2,194 | | | | (1,340 | ) | | | — | | | | 854 | |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 31,270 | | | | (6,260 | ) | | | 1,344 | | | | 26,354 | |
| | | | | | | | | | | | | | | | |
Income (loss) from operations | | | (4,892 | ) | | | 6,817 | | | | (1,344 | ) | | | 581 | |
| | | | |
Interest income | | | 449 | | | | — | | | | — | | | | 449 | |
Interest expense | | | (846 | ) | | | — | | | | — | | | | (846 | ) |
| | | | | | | | | | | | | | | | |
Income (loss) from operations before income taxes | | | (5,289 | ) | | | 6,817 | | | | (1,344 | ) | | | 184 | |
| | | | |
Provision for income taxes | | | 1,902 | | | | 64 | | | | — | | | | 1,966 | |
| | | | | | | | | | | | | | | | |
Net loss | | $ | (7,191 | ) | | $ | 6,753 | | | $ | (1,344 | ) | | $ | (1,782 | ) |
| | | | | | | | | | | | | | | | |
Net loss per share: | | | | | | | | | | | | | | | | |
Basic | | $ | (0.14 | ) | | | | | | | | | | $ | (0.03 | ) |
| | | | | | | | | | | | | | | | |
Diluted | | $ | (0.14 | ) | | | | | | | | | | $ | (0.03 | ) |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 51,237 | | | | | | | | | | | | 51,237 | |
Diluted | | | 51,237 | | | | | | | | | | | | 51,237 | |
KULICKE AND SOFFA INDUSTRIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | For the Fiscal Year Ended September 30, 2005 | |
| | Company Historical (3) | | | Sale of Wafer Test Business (2) | | | Pro Forma Adjustments | | | Company Pro Forma Combined | |
Net revenue | | $ | 561,274 | | | $ | (53,854 | ) | | $ | — | | | $ | 507,420 | |
| | | | |
Cost of sales | | | 419,695 | | | | (55,267 | ) | | | — | | | | 364,428 | |
| | | | | | | | | | | | | | | | |
Gross profit | | | 141,579 | | | | 1,413 | | | | — | | | | 142,992 | |
| | | | | | | | | | | | | | | | |
Selling, general and administrative | | | 94,473 | | | | (21,257 | ) | | | 4,861 | (4)(d) | | | 78,077 | |
Research and development | | | 41,025 | | | | (6,351 | ) | | | — | | | | 34,674 | |
Asset impairment | | | 48,820 | | | | (29,322 | ) | | | — | | | | 19,498 | |
Goodwill impairment | | | 51,756 | | | | (31,623 | ) | | | — | | | | 20,133 | |
Amortization of intangible assets | | | 6,225 | | | | (3,707 | ) | | | — | | | | 2,518 | |
Gain on sale of assets | | | (2,173 | ) | | | 818 | | | | — | | | | (1,355 | ) |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 240,126 | | | | (91,442 | ) | | | 4,861 | | | | 153,545 | |
| | | | | | | | | | | | | | | | |
Loss from operations | | | (98,547 | ) | | | 92,855 | | | | (4,861 | ) | | | (10,553 | ) |
| | | | |
Interest income | | | 2,228 | | | | — | | | | — | | | | 2,228 | |
Interest expense | | | (3,806 | ) | | | — | | | | — | | | | (3,806 | ) |
| | | | | | | | | | | | | | | | |
Loss from operations before income taxes | | | (100,125 | ) | | | 92,855 | | | | (4,861 | ) | | | (12,131 | ) |
| | | | |
Provision for income taxes | | | 3,957 | | | | 555 | | | | — | | | | 4,512 | |
| | | | | | | | | | | | | | | | |
Net loss | | $ | (104,082 | ) | | $ | 92,300 | | | $ | (4,861 | ) | | $ | (16,643 | ) |
| | | | | | | | | | | | | | | | |
Net loss per share: | | | | | | | | | | | | | | | | |
Basic | | $ | (2.02 | ) | | | | | | | | | | $ | (0.32 | ) |
| | | | | | | | | | | | | | | | |
Diluted | | $ | (2.02 | ) | | | | | | | | | | $ | (0.32 | ) |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 51,619 | | | | | | | | | | | | 51,619 | |
Diluted | | | 51,619 | | | | | | | | | | | | 51,619 | |
KULICKE AND SOFFA INDUSTRIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | For the Fiscal Year Ended September 30, 2004 | |
| | Company Historical (3) | | | Sale of Wafer Test Business (2) | | | Pro Forma Adjustments | | | Company Pro Forma Combined | |
Net revenue | | $ | 717,811 | | | $ | (78,283 | ) | | $ | — | | | $ | 639,528 | |
| | | | |
Cost of sales | | | 486,806 | | | | (64,947 | ) | | | — | | | | 421,859 | |
| | | | | | | | | | | | | | | | |
Gross profit | | | 231,005 | | | | (13,336 | ) | | | — | | | | 217,669 | |
| | | | | | | | | | | | | | | | |
Selling, general and administrative | | | 101,225 | | | | (22,998 | ) | | | 4,959 | (4)(d) | | | 83,186 | |
Research and development | | | 34,611 | | | | (3,954 | ) | | | — | | | | 30,657 | |
Resizing | | | (68 | ) | | | — | | | | — | | | | (68 | ) |
Asset impairment | | | 3,293 | | | | (110 | ) | | | — | | | | 3,183 | |
Amortization of intangible assets | | | 9,022 | | | | (5,911 | ) | | | — | | | | 3,111 | |
Gain on sale of assets | | | (1,023 | ) | | | — | | | | — | | | | (1,023 | ) |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 147,060 | | | | (32,973 | ) | | | 4,959 | | | | 119,046 | |
| | | | | | | | | | | | | | | | |
Income from operations | | | 83,945 | | | | 19,637 | | | | (4,959 | ) | | | 98,623 | |
| | | | |
Interest income | | | 1,109 | | | | — | | | | — | | | | 1,109 | |
Interest expense | | | (10,466 | ) | | | — | | | | — | | | | (10,466 | ) |
Charge on extinguishment of debt | | | (10,510 | ) | | | — | | | | — | | | | (10,510 | ) |
| | | | | | | | | | | | | | | | |
Income from continuing operations before income taxes | | | 64,078 | | | | 19,637 | | | | (4,959 | ) | | | 78,756 | |
Provision for income taxes | | | 7,386 | | | | (291 | ) | | | — | | | | 7,095 | |
| | | | | | | | | | | | | | | | |
Net income from continuing operations | | $ | 56,692 | | | $ | 19,928 | | | $ | (4,959 | ) | | $ | 71,661 | |
| | | | | | | | | | | | | | | | |
Net income per share from continuing operations: | | | | | | | | | | | | | | | | |
Basic | | $ | 1.12 | | | | | | | | | | | $ | 1.41 | |
| | | | | | | | | | | | | | | | |
Diluted | | $ | 0.90 | | | | | | | | | | | $ | 1.12 | |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 50,746 | | | | | | | | | | | | 50,746 | |
Diluted | | | 68,582 | | | | | | | | | | | | 68,582 | |
KULICKE AND SOFFA INDUSTRIES, INC.
UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS
(in thousands, except per share amounts)
| | | | | | | | | | | | | | | | |
| | For the Fiscal Year Ended September 30, 2003 | |
| | Company Historical (3) | | | Sale of Wafer Test Business (2) | | | Pro Forma Adjustments | | | Company Pro Forma Combined | |
Net revenue | | $ | 477,935 | | | $ | (62,720 | ) | | $ | — | | | $ | 415,215 | |
| | | | |
Cost of sales | | | 349,727 | | | | (55,060 | ) | | | — | | | | 294,667 | |
| | | | | | | | | | | | | | | | |
Gross profit | | | 128,208 | | | | (7,660 | ) | | | — | | | | 120,548 | |
| | | | | | | | | | | | | | | | |
Selling, general and administrative | | | 102,327 | | | | (16,747 | ) | | | 2,278 | (4)(d) | | | 87,858 | |
Research and development | | | 38,121 | | | | (3,188 | ) | | | — | | | | 34,933 | |
Resizing | | | (475 | ) | | | 103 | | | | — | | | | (372 | ) |
Asset impairment | | | 3,629 | | | | (1,691 | ) | | | — | | | | 1,938 | |
Amortization of intangible assets | | | 9,260 | | | | (5,723 | ) | | | — | | | | 3,537 | |
Loss on sale of product lines | | | 5,257 | | | | — | | | | — | | | | 5,257 | |
| | | | | | | | | | | | | | | | |
Total operating expenses | | | 158,119 | | | | (27,246 | ) | | | 2,278 | | | | 133,151 | |
| | | | | | | | | | | | | | | | |
Loss from operations | | | (29,911 | ) | | | 19,586 | | | | (2,278 | ) | | | (12,603 | ) |
| | | | |
Interest income | | | 940 | | | | — | | | | — | | | | 940 | |
Interest expense | | | (17,431 | ) | | | — | | | | — | | | | (17,431 | ) |
| | | | | | | | | | | | | | | | |
Loss from continuing operations before income taxes | | | (46,402 | ) | | | 19,586 | | | | (2,278 | ) | | | (29,094 | ) |
Provision for income taxes for continuing operations | | | 7,594 | | | | (90 | ) | | | — | | | | 7,504 | |
| | | | | | | | | | | | | | | | |
Net loss from continuing operations | | $ | (53,996 | ) | | $ | 19,676 | | | $ | (2,278 | ) | | $ | (36,598 | ) |
| | | | | | | | | | | | | | | | |
Net loss per share: | | | | | | | | | | | | | | | | |
Basic | | $ | (1.09 | ) | | | | | | | | | | $ | (0.74 | ) |
| | | | | | | | | | | | | | | | |
Diluted | | $ | (1.09 | ) | | | | | | | | | | $ | (0.74 | ) |
| | | | | | | | | | | | | | | | |
Weighted average shares outstanding: | | | | | | | | | | | | | | | | |
Basic | | | 49,695 | | | | | | | | | | | | 49,695 | |
Diluted | | | 49,695 | | | | | | | | | | | | 49,695 | |
NOTES TO UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL STATEMENTS
(1) | As reported in K&S’s unaudited quarterly report on Form 10-Q for the quarterly period ended December 31, 2005. |
(2) | Prepared by the Company from its accounting records. The wafer test business had not historically been managed or reported as a separate business and this financial information is prepared on a “carve-out” basis and reflects an allocation of certain corporate costs (see footnote (4(d)). These allocations have been prepared on a basis considered reasonable by management. |
(3) | As reported in K&S’s audited annual report on Form 10-K for the year ended September 30, 2005. |
(4) | Pro forma adjustments reflect only those adjustments which are directly attributable to the transaction and do not include the impact of contingencies. Pro forma adjustments include the following ($ in thousands): |
(a) | To record cash proceeds of $9,000, net of estimated transaction costs of $1,000 from the sale of the wafer test business. |
(b) | To add back certain assets of the wafer test business which will be retained by K&S, (consisting primarily of accounts receivable). |
(c) | Represents the estimated loss on sale of net assets of $11,069. |
(d) | To add back allocated corporate general and administrative expenses, incentive compensation, and stock-based compensation expense that are included in the wafer test business carve-out amounts that will not be eliminated with the disposal of the business and will continue to be incurred by K&S. |
| | | | | | | | | | | | | | | | |
| | Three Months Ended December 31, | | | Fiscal Year Ended December 31, |
| | 2005 | | 2004 | | | 2005 | | 2004 | | 2003 |
Corporate Allocated Expenses: | | | | | | | | | | | | | | | | |
| | | | | |
Selling, general and administrative | | $ | 912 | | $ | 1,382 | | | $ | 4,790 | | $ | 4,414 | | $ | 2,278 |
Incentive compensation | | | 191 | | | (38 | ) | | | 71 | | | 545 | | | — |
Stock-based compensation | | | 81 | | | — | | | | — | | | — | | | — |
| | | | | | | | | | | | | | | | |
| | $ | 1,184 | | $ | 1,344 | | | $ | 4,861 | | $ | 4,959 | | $ | 2,278 |
| | | | | | | | | | | | | | | | |